๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cellular IAP1 regulates TRAIL-induced apoptosis in human fetal cortical neural progenitor cells

โœ Scribed by Hui Peng; Yunlong Huang; Zhiyuan Duan; Nathan Erdmann; Dongsheng Xu; Shelley Herek; Jialin Zheng


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
422 KB
Volume
82
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

โœฆ Synopsis


Neural stem/progenitor cells (NPCs) are present in the developing and adult central nervous system. NPC apoptosis is an important aspect of normal brain development. We show that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor 2 is highly expressed on human NPCs derived from fetal cortex, yet TRAIL induces only minimal levels of apoptosis in NPCs. Caspase-8 mRNA and protein, an important factor in the TRAIL-mediated death pathway, is present at low levels in human NPCs. In contrast, inhibitors of apoptosis proteins (IAP), such as c-IAP1, are highly expressed. The transcription inhibitor actinomycin D sensitized human NPCs to TRAIL-induced apoptosis. Further, inhibition of cellular inhibitors of apoptosis protein 1 (c-IAP1) expression by small interfering RNA (siRNA) increased TRAIL-mediated caspase-3 activation and apoptosis; thus, c-IAP1 protects NPCs against TRAIL-induced apoptosis and suppresses caspase-3 activation. These findings illustrate the mechanisms for NPC resistance to apoptotic agonists such as TRAIL, and demonstrate a potentially important mechanism in CNS disease states.


๐Ÿ“œ SIMILAR VOLUMES


Naringenin up-regulates the expression o
โœ Cheng-Yun Jin; Cheol Park; Hye Jin Hwang; Gi-Young Kim; Byung Tae Choi; Wun-Jae ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 365 KB

While TRAIL is relatively non-toxic to normal cells, it can selectively induce apoptosis in many types of transformed cells. Nevertheless, some non-small cell lung cancer (NSCLC) cells are particularly resistant to the effects of TRAIL. Here, we report that in combination with naringenin exposure to

Evaluation of in vitro proliferative act
โœ Yonehiro Kanemura; Hideki Mori; Satoshi Kobayashi; Omedul Islam; Eri Kodama; Ats ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 733 KB

## Abstract To scale up human neural stem/progenitor cell (NSPC) cultures for clinical use, we need to know how long these cells can live ex vivo without losing their ability to proliferate and differentiate; thus, a convenient method is needed to estimate the proliferative activity of human NSPCs